|
| 37724848 | Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts. | Int J Cancer | 2024 |
| 37730481 | The effect of BRAF<sup>V600E</sup> mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-study. | J Geriatr Oncol | 2024 |
| 36000990 | Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer. | Int J Cancer | 2023 |
| 37666943 | Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. | Leukemia | 2023 |
| 35717628 | Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study. | Cancer Med | 2023 |
| 37240646 | Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study). | J Clin Med | 2023 |
| 37173961 | Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome. | Cancers (Basel) | 2023 |
| 37029990 | CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research. | Acta Oncol | 2023 |
| 36996624 | Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial. | Eur J Cancer | 2023 |
| 36724681 | An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. | EBioMedicine | 2023 |
| 36581138 | Authors' reply-A sensitivity analysis of the RAPIDO clinical trial. | Ann Oncol | 2023 |
| 36871393 | The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial. | ESMO Open | 2023 |
| 36831497 | Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study. | Cancers (Basel) | 2023 |
| 36494261 | Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study. | J Geriatr Oncol | 2023 |
| 36661037 | Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial. | Ann Surg | 2023 |
| 36657089 | Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial. | J Clin Oncol | 2023 |
| 34671130 | Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients. | Br J Cancer | 2022 |
| 35406485 | Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study. | Cancers (Basel) | 2022 |
| 35798468 | Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. | ESMO Open | 2022 |
| 35470381 | Mucinous rectal cancers: clinical features and prognosis in a population-based cohort. | BJS Open | 2022 |
| 35447283 | Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial. | Radiother Oncol | 2022 |
| 36551723 | Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters. | Cancers (Basel) | 2022 |
| 36308441 | Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M). | JNCI Cancer Spectr | 2022 |
| 36233472 | The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study. | J Clin Med | 2022 |
| 35986249 | Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study. | BMC Cancer | 2022 |
| 36152023 | Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer. | Acta Oncol | 2022 |
| 35254485 | Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus. | Eur Radiol | 2022 |
| 35251991 | <i>KRAS</i>-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer. | Front Oncol | 2022 |
| 34853022 | Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35077204 | Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy. | J Clin Oncol | 2022 |
| 33301740 | Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. | Lancet Oncol | 2021 |
| 33548338 | Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma. | Int J Radiat Oncol Biol Phys | 2021 |
| 33706249 | The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types. | EBioMedicine | 2021 |
| 33561507 | Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma. | Int J Radiat Oncol Biol Phys | 2021 |
| 33662297 | Interpreting the RAPIDO trial: factors to consider - Authors' reply. | Lancet Oncol | 2021 |
| 33527488 | Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomized clinical trial. | Scand J Med Sci Sports | 2021 |
| 33689551 | Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer. | Acta Oncol | 2021 |
| 35040942 | Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial. | BJS Open | 2021 |
| 34771707 | The Immune Landscape of Colorectal Cancer. | Cancers (Basel) | 2021 |
| 34622145 | Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. | J Transl Genet Genom | 2021 |
| 34830914 | hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. | Cancers (Basel) | 2021 |
| 33992542 | Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis. | Clin Colorectal Cancer | 2021 |
| 34015686 | Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone. | Cancer Treat Rev | 2021 |
| 34073363 | Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study. | Cancers (Basel) | 2021 |
| 33961700 | Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer. | Int J Cancer | 2021 |
| 33952471 | Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence. | Anticancer Res | 2021 |
| 34259966 | Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study. | J Patient Rep Outcomes | 2021 |
| 34279175 | Accurate population-based model for individual prediction of colon cancer recurrence. | Acta Oncol | 2021 |
| 33341192 | TOSCA-a delicious Swedish almond cake, an Italian opera and an Italian trial with important new data. | Ann Oncol | 2021 |
| 33453311 | Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery? | Radiother Oncol | 2021 |